This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Signpath Pharma, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Peter Sordillo
Introduction
Peter Sordillo is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of proliferative disorders. His innovative approach combines the use of liposomal curcumin or curcuminoids with specific dosing regimens to enhance therapeutic outcomes.
Latest Patents
Peter Sordillo holds a patent for "Dosing regimens for treatment of proliferative disorders." This invention includes compositions and methods for treating a proliferative disorder by administering a therapeutically effective amount of liposomal curcumin or curcuminoids. The dosing regimen involves administering at least 100 mg/m² once per week over a period of 8 hours, tailored for human subjects in need of treatment.
Career Highlights
Peter Sordillo is currently associated with Signpath Pharma, Inc., where he continues to develop and refine his innovative ideas. His work focuses on improving treatment methodologies and patient outcomes through advanced therapeutic strategies.
Conclusion
Peter Sordillo's contributions to the field of medicine through his patent and work at Signpath Pharma, Inc. highlight his commitment to innovation in treating proliferative disorders. His research and inventions pave the way for more effective treatment options for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile